Examination of IL-1 beta level as an inflammasome marker in Alzheimer's disease

Bulut O., Tanburoglu A., Boluk G., Demir N., Eren E., Vurgun U., ...Daha Fazla

NEUROLOGICAL SCIENCES AND NEUROPHYSIOLOGY, cilt.36, sa.3, ss.141-147, 2019 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 36 Sayı: 3
  • Basım Tarihi: 2019
  • Doi Numarası: 10.5152/nsn.2019.10324
  • Dergi Adı: NEUROLOGICAL SCIENCES AND NEUROPHYSIOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.141-147
  • Anahtar Kelimeler: Alzheimer's disease, cytokine, dementia, enzyme linked immunosorbent assay, interleukin-1 beta, MILD COGNITIVE IMPAIRMENT, CELL-ADHESION MOLECULE-1, PLASMA-LEVELS, TNF-ALPHA, SERUM, CYTOKINES, INTERLEUKIN-1, EXPRESSION, DEMENTIA, ASTROCYTES
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Objective: Interleukin (IL)-1 beta is believed to be responsible for the neurotoxicity of amyloid plaques in Alzheimer's disease (AD). In the present study, serum levels of IL-1 beta, and correlations with clinical features and neuropsychiatric test results were examined.